Prospects for effective oral iron chelation therapy in man with 1,2-dimethyl-3-hydroxypyrid-4-one and other alpha-ketohydroxypyridines.
Kontoghiorghes
G J
GJ
Department of Haematology, Royal Free Hospital Medical School, London, UK.
Bartlett
A N
AN
Hoffbrand
A V
AV
D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D000077543:Deferiprone; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008875:Middle Aged; D009436:Neural Tube Defects / Q000628:therapy*; D011728:Pyridones / Q000627:therapeutic use*; D013789:Thalassemia / Q000628:therapy*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D007501:Iron